Benchmarks ended in the green for the second-straight session on Tuesday, banking on gains among energy shares. A rally in oil prices helped energy shares settle in the green. Meanwhile, upbeat monthly U.S. auto sales report along with possibility of a new deal between Office Depot and Staples boosted investor sentiment. Encouraging news emanating from Greece also added to the […]
NEW YORK (MarketWatch) — The U.S. stocks were under pressure on Wednesday as crude-oil prices gave up part of the gains racked up over a four-day trading span, while a report on private-sector hiring disappointed.Private employers added 213,000 jobs in January, according Automatic Data Processing Inc. Economists use the number to get a feel for the official jobs report due […]
Jay Yarow
Jan. 28, 2015, 7:39 AM
7,149
Smithsonian/Renegade PicturesSee Also15 Mind-Blowing Facts About Apple’s Latest QuarterApple Has Shipped 1 Billion iOS DevicesApple Crushes EarningsAfter digesting Apple’s historic earnings report, investors have decided to buy more Apple stock.Apple is up 9% in premarket trading. It was up by only 5% after-hours Tuesday night, so investors have clearly gotten more excited about Apple’s potential.Apple […]
Healthcare
RayVa Patent Award Sends Apricus Biosciences Inc (APRI) Stock Trading Up
Apricus Biosciences announces on Tuesday that it has been awarded Rayva’s Patent by USPTO; stock soars by 15.58%
APRI
By: Martin BlancPublished: Jan 28, 2015 at 11:41 am EST
Apricus Biosciences Inc. (NASDAQ:APRI) is trading up by around 15.58% as of 11:14 AM EST. The buying spree on the stock followed the announcement […]
Disappointing earnings results dragged down benchmarks on Tuesday to their biggest one-day losses in three weeks. Major market movers including Microsoft and Caterpillar reported dismal earnings reports that dented investor sentiment yesterday. Moreover, discouraging durable order report also had a negative impact on the markets.For a look at the issues currently facing the markets, make sure to read today’s Ahead […]
LONDON, January 28, 2015 /PRNewswire/ –Investor-Edge has initiated coverage on the following equities: Halozyme Therapeutics Inc. (NASDAQ: HALO), Agenus Inc. (NASDAQ: AGEN), Biogen Idec Inc. (NASDAQ: BIIB), ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), and Peregrine Pharmaceuticals Inc. (NASDAQ: PPHM). Free research report on Halozyme Therapeutics can be accessed at http://get.Investor-Edge.com/pdf/?c=Halozyme%20Therapeutics&d=28-Jan-2015&s=HALO. On Tuesday, January 27, 2015, the NASDAQ Composite ended at 4,681.50, […]
What Investors Are Looking At In The Stem Cell Sector
By iCELL News on January 14, 2015 · Sector
Stem cell stocks did poorly in 2014.However, many of these companies have catalysts in the first quarter of 2015 that could bring attention to the sector.In anticipation of a Phase 2 clinical update, Brainstorm Cell Therapeutics IncBCLI 1.89%stock rallied nearly 100 percent. The […]
Benchmarks continued to suffer losses on Tuesday due to another slump in oil prices. Political uncertainty in Greece and Bill Gross’ dismal outlook for 2015 also dented investor mood. Further, data showing weaker-than-expected growth in the U.S. service sector and a drop in factory orders for four consecutive months weighed on investor sentiment.For a look at the issues currently facing […]
View gallery.It’s been a rough couple of days for biotech stocks.To start, Gilead Sciences, Inc. (NASDAQ: GILD) has dropped from a high of almost $110 per share on Friday to a low of $86 on Tuesday.Many other big-name biotechs, such as Amgen, Inc. (NASDAQ: AMGN), Biogen Idec Inc (NASDAQ: BIIB) and Valeant Pharmaceuticals Intl Inc (NYSE: VRX) have fallen with […]
Benchmarks mostly settled in the green on Tuesday banking on better-than-expected revision to third quarter GDP numbers. The Dow closed above the 18K mark for the first time ever and notched up a record closing level for the 36th time this year. Almost 119 trading sessions have gone by since the index had crossed the 17K mark. The S&P 500 […]
